Given the central role for MYCN and its target genes in high-risk neuroblastoma, the abrupt and potent depletion of MYCN upon HIF2α induction strongly argues against an oncogenic role for HIF2α in this particular disease. The gene discussed is EPAS1; the disease is neuroblastoma.